Blog

Chromosomal Microarray (CMA) in Children with Psychiatric Disorders: Who to Test and What to Expect

August 9, 2018
The International Society of Psychiatric Genetics updated their Genetic Testing Statement in 2017 and recommended CMA testing for people with autism spectrum disorder (ASD), schizophrenia, or other psychiatric disorders, especially when accompanied by intellectual disability or other health concerns.

Brooke Spangler, MS, LCGC
Read more

Looking Outside of Guidelines for Genetic Testing

April 10, 2018
Since the publication of many of the guidelines regarding CMA testing, studies have been done which look at the diagnostic yield of CMA and role of copy number variants for a variety of clinical presentations. Examining these studies can provide insight into a broader spectrum of patients you see in your practice who could benefit from CMA testing.

Annie Baxter, MS, LCGC
Read more

Genetic testing framework for neurodevelopmental disorders and epilepsy plus

March 6, 2018
Chromosomal Microarray with reflex to whole exome sequencing: beneficial genetic testing process for patients with neurodevelopmental disorders and patients with epilepsy plus.

Lauren Miller, MS, LCGC
Read more

Frequently Asked Questions (FAQ) with our Lineagen Genetic Counselors

March 6, 2018
Lineagen’s team of genetic counselors wear many hats as part of our clinical team. One of their favorite roles is acting as information resources for the patients and providers we serve. Here are some of the questions we receive most frequently from providers.

Deanna Leingang, MS, LCGC
Read more